Tumourigenesis of HCC is regulated by a series of pathways, such as Wnt/β-catenin, Notch, EGFR, RAS/MAPK/ERK, AKT/mTOR and FAK/SRC4–8. Here, PTK2 is linked to hepatocellular carcinoma.